----------------------------- ----------------------------
Volume 3, Issue 2 (autumn and winter 2017)                   JMIS 2017, 3(2): 49-55 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Aghazadeh S, Nemati M, Sharif Nia E, Hamishehkar H. The cost benefit of drugs and medical consumables in common global gynecological surgeries of two educational-therapeutic hospitals of Tabriz city. JMIS. 2017; 3 (2) :49-55
URL: http://jmis.hums.ac.ir/article-1-144-en.html
Department of Clinical Pharmacy, Tabriz University of Medical Science, Tabriz, Iran.
Abstract:   (5139 Views)
Aim: One of the recent reimbursement methods implemented by insurance organizations is the global system, where the accuracy of estimated tariff by this organization, especially in the field of drugs and medical consumables toward the real costs of the cases, is questioned. The purpose of this study is comparing the drugs and medical consumables’ cost in global system over the insurance tariff.
Methods: In this descriptive-analytical study the average cost of drugs and medical consumables of two university tertiary affiliated with gynecological hospitals of Tabriz university of medical science, were evaluated with global tariff; and reasons of different cost of drugs and medical consumables between two hospitals was reviewed. In this research we study 8 common gynecological surgeries for 320 patients in the first quarter of the year, and the related information is extracted from hospital information system (HIS). We used Spss software for statistical analysis.
Results: The total cost of drugs and medical consumables in caesarean, Myomectomy, accouchement, Hysterectomy and abortion is significantly more than Global tariff, and in ectopic pregnancy the total cost is significantly lesser than the Global tariff for the cases (P-Value<0.05). In Cystectomy and curettage surgeries compared to Global tariff, there is no statistically significant difference (P-Value>005). By comparing the two hospitals, it can be investigated that, in caesarean, accouchement and Myomectomy surgeries the costs of "A" hospital is statistically significantly more than "B" hospital (P-Value<0.05); and in Hysterectomy, Cystectomy, abortion, ectopic pregnancy and curettage, there is no statistically significant difference between the two hospitals.
Conclusion: It seems that, drugs and medical consumables tariff in global surgeries is not commensurate with its real costs in governmental hospitals. Our findings show that, these tariffs will need to be reviewed in order to avoid financial loss in governmental hospitals.
Full-Text [PDF 605 kb]   (1406 Downloads)    
Type of Study: Research | Subject: General
Received: 2017/11/29 | Accepted: 2018/03/25 | Published: 2018/03/25

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | Journal of Modern Medical Information Sciences

Designed & Developed by : Yektaweb